Johnson & Johnson has paused shipment of its COVID-19 vaccine in the United States while the Food and Drug Administration investigates a factory mixup that ruined roughly 15 million doses of the vaccine.
Workers at a Baltimore plant run by Emergent BioSolutions, a manufacturing partner to Johnson & Johnson and AstraZeneca, reportedly mixed up the vaccines’ ingredients several weeks ago, according to the New York Times.Read more here.
No comments:
Post a Comment